Navigation Links
Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors

HDAC Inhibitor MGCD0103 Demonstrates substantial Response Rate in Two Clinical Trials

Clinical Data Presented on Pilot Pharmacokinetic Study of Oral Azacitidine

Exelixis Reports Comprehensive XL880 Phase I Data At ASCO

Exelixis Reports Integrated Data From Phase II Clinical Trials of XL999 at ASCO

Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors

Studies Investigating Vidaza in Alternate Dosing Schedules in MDS and in Combination with Valproic Acid for Solid Tumors Presented at the American Society of Clinical Oncology 43rd Annual Meeting

* In alternate dose trial, transfusion independence achieved for 65% to 80% of patients transfusion dependent at baseline

CHICAGO, Ill., June 2, 2007 - Pharmion Corporation (NASDAQ: PHRM) reported today the interim results of several Vidaza (azacitidine for injection) studies in the treatment of hematologic malignancies and advanced solid tumors. These data were presented at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill. (June 1-5, 2007). Pharmion's epigenetic anti-cancer products, which include Vidaza, MCGD0103 and oral Azacitidine, are being investigated in the treatment of hematologic malignancies and solid tumors and are the subject of poster and oral presentations at the Meeting.

"As we continue to evaluate alternative dosing and schedules for Vidaza in MDS, and its potential in solid tumors, we are increasingly impressed with the activity this drug has in multiple tumor types," said Patrick J. Mahaffy, president and CEO of Pharmion. "These studies will help provide us with insight not only into the continuing development of parenteral Vidaza, but, in particular, provide us direction for the development of oral azacitidine."

Tolerability and hematologic improvement assessed using three alternative dosing schedules of azacitidine
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:10/25/2014)... 24, 2014 Advanced Photonix ® (NYSE MKT: ... 2014) financial results on Monday, November 10, 2014. A press ... close of the market and the Company will host a ... p.m. EDT on the same day. Participating in ... Director), Rob Risser (COO and Director), and ...
(Date:10/25/2014)... SANTA ROSA, Calif. , Oct. 24, 2014 /PRNewswire-USNewswire/ ... he was ordering large quantities of multiple controlled substances, ... patient care. They also reported that Dr. Gurney was ... Medical Board reported that one of his employees said ... his care and treatment of patients." Dr. ...
(Date:10/25/2014)... Oct. 24, 2014 Best Practices designed ... leaders with a forum for sharing insights about ... developed a mechanism for creating and sharing solutions ... key findings from the Medical Affairs Consortium survey. ... analysis for the first roundtable of the 2014-2015 ...
Breaking Medicine Technology:Advanced Photonix to Webcast Fiscal 2015 Second Quarter Earnings 2Doctors That Harm: The Real Stories Insurance Companies Against Prop 46 Don't Want You To Know, Part 8 of Consumer Watchdog Campaign Series 2Doctors That Harm: The Real Stories Insurance Companies Against Prop 46 Don't Want You To Know, Part 8 of Consumer Watchdog Campaign Series 3Strong Participation in Best Practices' Medical Affairs Consortium Survey 2
... 2011 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. (NYSE AMEX: ... in China, today announced financial results for the quarter ended June ... Highlights Revenue increased 18% to $19.6 ... Cashflow from operations rose 10% to $3.6 million from $3.3 million ...
... N.J., Aug. 11, 2011 Pacira Pharmaceuticals, Inc. (Nasdaq: ... today announced financial results for the second quarter ended ... of its pre-commercial and launch strategies for EXPAREL™, and ... continued to aggressively execute our launch strategy for EXPAREL ...
Cached Medicine Technology:China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results 2China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results 3China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results 4China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results 5China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results 6China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results 7China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results 8China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results 9China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results 10Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results 2Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results 3Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results 4Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results 5Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results 6Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results 7Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results 8Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results 9Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results 10
(Date:10/25/2014)... LunaDress is excited to announce the ... today. According to the company’s CEO, these amazing ... dwelling in the UK. The company’s new collection features ... all unpretentious and elegant. , These new designs are ... top dress experts. LunaDress strives to provide affordable special ...
(Date:10/25/2014)... October 26, 2014 BioSkinLaser.Com, the leading ... most advanced and improved laser treatments for its customers. ... treatments like the lip enhancement treatment . It ... specific focus areas of each customer. , BioSkinLaser.Com has ... reduction NYC . The company cited that it created ...
(Date:10/25/2014)... Background: , In 1998 Bob Savage founded the Connecticut ... the field of establishing recovery community organizations. Bob had ... he retired, he set out to answer a couple questions ... , 1. Where are the people in recovery when ... Can the recovery community be organized to advocate for issues ...
(Date:10/25/2014)... Homeowners that are wondering how they can ... no more. Clean Crawls gives 5 signs of ... when it comes to insulation in their recently released ... by Clean Crawls, can cause problems throughout your entire ... has deteriorated, become damp, or been infested with pests ...
(Date:10/25/2014)... Steven Reinberg HealthDay Reporter ... causes common cold sores -- herpes simplex -- might increase ... suggest. In fact, being a carrier of certain antibodies ... the researchers found. "The identification of a treatable ... a breakthrough," said lead researcher Dr. Hugo Lovheim, an associate ...
Breaking Medicine News(10 mins):Health News:LunaDress Now Release Its Designer Inspired Fashion Wedding Dresses For Customers Dwelling In The UK 2Health News:BioSkinLaser.Com Now Offers Advanced Medical Aesthetics Procedures 2Health News:BioSkinLaser.Com Now Offers Advanced Medical Aesthetics Procedures 3Health News:CCAR Accepting Nominations for the Bob Savage Recovery Advocate of the Year Award 2Health News:5 Signs Indicating That Insulation Needs Replacing as Told By Clean Crawls in Recent Article 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3
... the Kaiser Family Foundation, Planned Parenthood and Partners Triggers ... STD Testing Doubles at Many Planned Parenthood Clinics During ... 2 In recognition of National STD Awareness Month ... Planned Parenthood Federation of America (PPFA) ...
... the complex neurocircuitry behind weight gain and glucose control, scientists ... in the process. But within the myriad twists and turns ... hormone travels to exert its influence have remained a mystery. ... Deaconess Medical Center (BIDMC) sheds further light on the subject. ...
... and DULUTH, Minn., June 2 MEDNETWorld.com (MEDNET), ... connectivity and clinical applications, and the Community Health ... Lookup System, allowing electronic clinical data exchange for ... providers to securely look up patient records and ...
... rely on them, experts say , TUESDAY, June 2 ... proton pump inhibitors and histamine-2 receptor antagonists relieve stomach ... hip and thigh fractures, a new study confirms. , ... other studies, supports the idea that these drugs increase ...
... 2009) -- The first artificial organ for liver patients ... Assist Device, or ELAD, is a bedside system that ... like a real liver does. NewYork-Presbyterian Hospital/Columbia University ... number of hospitals in the U.S. offering this therapy ...
... Migrant Children in South Africa , ... international advocacy and aid organization founded by actors George Clooney ... Pitt , producer Jerry Weintraub and human rights lawyer ... a grant of $438,000 to assist at-risk Zimbabwean refugee children living ...
Cached Medicine News:Health News:MTV'S GYT Campaign Spurs Nationwide Movement to 'Get Yourself Tested' 2Health News:MTV'S GYT Campaign Spurs Nationwide Movement to 'Get Yourself Tested' 3Health News:MTV'S GYT Campaign Spurs Nationwide Movement to 'Get Yourself Tested' 4Health News:MTV'S GYT Campaign Spurs Nationwide Movement to 'Get Yourself Tested' 5Health News:MTV'S GYT Campaign Spurs Nationwide Movement to 'Get Yourself Tested' 6Health News:Study further expands understanding of leptin's role in brain neurocircuitry 2Health News:Study further expands understanding of leptin's role in brain neurocircuitry 3Health News:Minnesota Healthcare Community to Build State-of-the-Art Health Information Exchange 2Health News:Powerful Antacids Raise Chances of Fracture 2Health News:Powerful Antacids Raise Chances of Fracture 3Health News:Artificial liver may extend lives 2Health News:Not On Our Watch Grant to UNICEF to Support Critical Protection Programs for Zimbabwean Refugee Children 2Health News:Not On Our Watch Grant to UNICEF to Support Critical Protection Programs for Zimbabwean Refugee Children 3
... The Compact Sigma is designed to ... Quick, precise mechanical coupling eliminates clumsy ... be performed as well. Dorniers patented ... too. ,Positioning is simple using the ...
... The Dornier Lithotripter S II is ideally suited ... both an excellent stone therapy system and an ... wave source, the DoLi S II provides successful ... to its flexible table design, conducting URS and ...
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
Medicine Products: